Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 15 studies | 33% ± 14% | |
| astrocyte | 13 studies | 34% ± 14% | |
| macrophage | 11 studies | 32% ± 12% | |
| microglial cell | 11 studies | 30% ± 9% | |
| oligodendrocyte | 11 studies | 30% ± 11% | |
| GABAergic neuron | 10 studies | 48% ± 24% | |
| glutamatergic neuron | 10 studies | 53% ± 24% | |
| oligodendrocyte precursor cell | 10 studies | 34% ± 14% | |
| fibroblast | 10 studies | 28% ± 11% | |
| adipocyte | 9 studies | 34% ± 10% | |
| smooth muscle cell | 7 studies | 27% ± 8% | |
| neuron | 6 studies | 40% ± 18% | |
| interneuron | 6 studies | 55% ± 23% | |
| retinal cone cell | 6 studies | 26% ± 8% | |
| endothelial cell of lymphatic vessel | 6 studies | 26% ± 8% | |
| pericyte | 6 studies | 28% ± 8% | |
| myeloid cell | 5 studies | 28% ± 5% | |
| epithelial cell | 5 studies | 40% ± 16% | |
| cardiac muscle cell | 5 studies | 37% ± 11% | |
| dendritic cell | 5 studies | 24% ± 4% | |
| T cell | 5 studies | 23% ± 5% | |
| monocyte | 5 studies | 31% ± 7% | |
| type I pneumocyte | 5 studies | 33% ± 8% | |
| type II pneumocyte | 5 studies | 35% ± 11% | |
| granule cell | 4 studies | 30% ± 8% | |
| mast cell | 4 studies | 25% ± 7% | |
| ciliated cell | 4 studies | 34% ± 10% | |
| Mueller cell | 4 studies | 25% ± 5% | |
| amacrine cell | 4 studies | 26% ± 2% | |
| retina horizontal cell | 4 studies | 23% ± 5% | |
| retinal rod cell | 4 studies | 30% ± 5% | |
| club cell | 4 studies | 30% ± 9% | |
| GABAergic interneuron | 3 studies | 39% ± 5% | |
| B cell | 3 studies | 25% ± 2% | |
| CD4-positive, alpha-beta T cell | 3 studies | 20% ± 4% | |
| GABAergic amacrine cell | 3 studies | 27% ± 3% | |
| glycinergic amacrine cell | 3 studies | 23% ± 4% | |
| retinal ganglion cell | 3 studies | 27% ± 6% | |
| endothelial cell of vascular tree | 3 studies | 26% ± 12% | |
| hepatocyte | 3 studies | 27% ± 8% | |
| ependymal cell | 3 studies | 32% ± 11% | |
| alveolar macrophage | 3 studies | 36% ± 8% | |
| natural killer cell | 3 studies | 21% ± 4% | |
| respiratory goblet cell | 3 studies | 29% ± 13% | |
| lymphocyte | 3 studies | 31% ± 10% | |
| basal cell | 3 studies | 34% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1620.81 | 1445 / 1445 | 100% | 12.14 | 183 / 183 |
| prostate | 100% | 1799.20 | 245 / 245 | 100% | 9.74 | 501 / 502 |
| ovary | 100% | 2046.65 | 180 / 180 | 100% | 7.58 | 429 / 430 |
| lung | 100% | 1917.66 | 577 / 578 | 100% | 10.07 | 1153 / 1155 |
| breast | 100% | 1934.78 | 459 / 459 | 100% | 14.45 | 1114 / 1118 |
| brain | 100% | 1947.12 | 2636 / 2642 | 100% | 11.22 | 704 / 705 |
| bladder | 100% | 1808.38 | 21 / 21 | 99% | 8.04 | 501 / 504 |
| kidney | 100% | 1381.29 | 89 / 89 | 99% | 8.63 | 895 / 901 |
| thymus | 100% | 1693.87 | 653 / 653 | 99% | 9.45 | 599 / 605 |
| intestine | 100% | 1914.90 | 966 / 966 | 99% | 8.02 | 521 / 527 |
| stomach | 100% | 1302.31 | 359 / 359 | 99% | 8.89 | 282 / 286 |
| adrenal gland | 100% | 2018.33 | 258 / 258 | 98% | 7.67 | 225 / 230 |
| pancreas | 99% | 983.48 | 324 / 328 | 99% | 8.03 | 176 / 178 |
| skin | 100% | 2491.07 | 1809 / 1809 | 97% | 7.75 | 460 / 472 |
| uterus | 100% | 2071.54 | 170 / 170 | 97% | 6.61 | 446 / 459 |
| liver | 98% | 805.10 | 222 / 226 | 91% | 4.32 | 369 / 406 |
| adipose | 100% | 1886.32 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1782.72 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 5.53 | 29 / 29 |
| spleen | 100% | 2161.24 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 6.03 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.42 | 1 / 1 |
| muscle | 98% | 826.14 | 786 / 803 | 0% | 0 | 0 / 0 |
| heart | 98% | 965.33 | 842 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 97% | 1382.82 | 905 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 91% | 5.11 | 73 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0001662 | Biological process | behavioral fear response |
| GO_0099575 | Biological process | regulation of protein catabolic process at presynapse, modulating synaptic transmission |
| GO_0031146 | Biological process | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process |
| GO_2000300 | Biological process | regulation of synaptic vesicle exocytosis |
| GO_0019005 | Cellular component | SCF ubiquitin ligase complex |
| GO_0098978 | Cellular component | glutamatergic synapse |
| GO_0098793 | Cellular component | presynapse |
| GO_0005829 | Cellular component | cytosol |
| GO_0098685 | Cellular component | Schaffer collateral - CA1 synapse |
| GO_0005515 | Molecular function | protein binding |
| Gene name | FBXL20 |
| Protein name | F-box and leucine rich repeat protein 20 F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like) F-box and leucine rich repeat protein 20 (F-box and leucine-rich repeat protein 20, isoform CRA_a) |
| Synonyms | FBL2 hCG_1813440 |
| Description | FUNCTION: Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex. Role in neural transmission (By similarity). . |
| Accessions | ENST00000264658.11 [Q96IG2-1] ENST00000647139.1 ENST00000581781.1 ENST00000577399.5 J3QKL3 J3KTA1 Q96IG2 A0A2R8Y677 ENST00000394294.7 [Q96IG2-2] ENST00000583610.5 [Q96IG2-1] |